Researchers protecting
health and prosperity
It’s the fifth anniversary of the COVID-19 pandemic and McMaster researchers are developing a better vaccine, using AI to power drug discovery, and sharing evidence-based ways to protect the health of communities and the economy.
For over 50 years, McMaster University has been at the forefront of vaccinology, making groundbreaking contributions that have shaped the field. From pioneering critical research tools to leading innovation in next-generation inhaled vaccines, McMaster’s impact on global health is profound and far-reaching.
Nearly three decades after the last time a new class of antibiotics reached the market, McMaster researchers have made a breakthrough discovery that could hold the key to addressing antimicrobial resistance.
A team led by researcher Gerry Wright has identified a strong candidate to challenge some of the most drug-resistant bacteria on the planet: a new class of antibiotics called lariocidin.
The discovery could address a critical need for new antimicrobial medicines, as bacteria and other microorganisms evolve new ways to withstand existing drugs. AMR is one of the top global public health threats, and Wright says discovering new drugs is a key part of the solution.
Professor, Human Resources & Management
Tariffs expertise: • Impact on the job market • How companies can deal with economic uncertainty • Worker retraining due to changing market
Professor, Pathology & Molecular Medicine
MIRCIM Session 7: Infectious Diseases "Vaccinations for people with severe comorbidity: Current state of the art"
Sign up to receive future communications from McMaster University
Canada’s Nuclear University Nuclear Medicine Health Innovation Environment & Sustainability
Discover Map
X Facebook Instagram LinkedIn
Contact Terms & Conditions Privacy Policy